Phibro Animal Health Corporation — Company profile
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 38.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.58B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock’s diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Details
| Name | Phibro Animal Health Corporation |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 2605 |
| Founded | 1946 |
| Ipo Date | 2014-04-11 |
| Ceo | Daniel Bendheim |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| Isin | US71742Q1067 |
| Cusip | 71742Q106 |
| Cik | 0001069899 |
| Sic | 2834 |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Daniel M. Bendheim J.D. | Chief Executive Officer, President and Director |
| Jack Clifford Bendheim | Executive Chairman |
| Glenn C. David | Chief Financial Officer |
| Larry L. Miller | Chief Operating Officer |
| Judith A. Weinstein | Senior Vice President, General Counsel and Corporate Secretary |
| Jonathan Bendheim | Executive Vice President of Talent, Technology and Business Development and Director |
| Lisa Ann Escudero | Senior Vice President of Human Resources |
| Ramon Fuenmayor | President South America Region |
| Samson Li | President of Asia Pacific Region |
| Todd Armstrong | President of North American Region |
Contact
| Address | Glenpointe Centre East, 3rd Floor, Teaneck, New Jersey 07666-6712, United States |
| Phone | 201 329 7300 |
| Website | https://www.pahc.com |